Abbott Laboratories (ABT)
(Delayed Data from NYSE)
$112.61 USD
-0.73 (-0.64%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $112.65 +0.04 (0.04%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth A Momentum C VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Top 28% (70 out of 252)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.55 | 1.69 | 9.99 |
Current Quarter Estimate | 1.20 | 7.55 | 61.00 |
Year Ago Quarter Estimate | 1.14 | 4.52 | 54.84 |
Next Quarter Estimate | 1.34 | 8.31 | 63.00 |
Next Year Estimate | 5.13 | 45.15 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 4.95 | 12.70 | 15.67 |
Next Year | 10.09 | 22.20 | 11.34 |
Last 5 Years | 9.00 | 2.90 | 8.10 |
Next 5 Years | 8.60 | 15.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 25.47 | 4.88 |
Price/Book (MRQ) | 4.98 | 2.24 |
Price/Cash Flow (MRFY) | 17.82 | 11.85 |
Dividend Yield | 1.94% | 0.00% |
Net Profit Margin (TTM) | 13.65% | -9.36% |
Return on Equity (TTM) | 20.18% | -2.30% |
Debt to Equity (MRQ) | 0.33 | 22.47 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.